Stuart H. Bloom
Expertise in
11
conditions

Dr. Stuart H. Bloom

Hematology Oncology | Oncology
909 Fulton Street Southeast, 
Minneapolis, MN 
Accepting New Patients
Offers Telehealth
Expertise in
11
conditions
909 Fulton Street Southeast, 
Minneapolis, MN 

Overview

Stuart Bloom is a Hematologist Oncology specialist and an Oncologist practicing medicine in Minneapolis, Minnesota.

Dr. Bloom is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Multiple Myeloma, and Paget Disease of the Breast.

Dr. Bloom is board certified in Hematology: American Board Of Internal Medicine, 2001 and Medical Oncology: American Board Of Internal Medicine, 2002. He is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 1 clinical trial. Dr. Bloom is currently accepting new patients.

Specialties

Hematology Oncology
Oncology

Licenses

Internal Medicine in MN

Board Certifications

Hematology: American Board Of Internal Medicine, 2001
Medical Oncology: American Board Of Internal Medicine, 2002

Hospital Affiliations

M Health Fairview Woodwinds Hospital
M Health Fairview University Of Mn Medical Center
M Health Fairview Southdale Hospital
M Health Fairview Ridges Hospital
M Health Fairview St John's Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Metropolitan Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
Nippon Life
  • INSURANCE PLAN
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
PreferredOne
  • HMO
  • OTHER COMMERCIAL
Primewest Health System
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Sanford Health
  • HMO
  • PPO
South Country Health Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

M Health Fairview Masonic Cancer Clinic
909 Fulton Street Southeast, Minneapolis, MN 55455

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double Blind, Multicenter, Parallel-group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men With Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy
A Randomized, Double Blind, Multicenter, Parallel-group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men With Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy
Enrollment Status: Completed
Publish Date: April 06, 2021
Intervention Type: Biological
Study Phase: Phase 3

3 Total Publications

Plasma extracellular vesicle proteomics nominates candidate biomarkers of 177Lu-PSMA-617 outcomes in metastatic prostate cancer patients.
Plasma extracellular vesicle proteomics nominates candidate biomarkers of 177Lu-PSMA-617 outcomes in metastatic prostate cancer patients.
Journal: Cell reports. Medicine
Published: August 15, 2025
Similar Doctors
Expertise in
29
conditions
Dr. Veronika Bachanova
Hematology Oncology
Expertise in
29
conditions
Dr. Veronika Bachanova
Hematology Oncology
Referral may be required

M Health Fairview Blood And Marrow Transplant Program Minneapolis

909 Fulton Street Southeast, Suite 214, 
Minneapolis, MN 
 (0.1 miles away)
612-676-4200
Languages Spoken:
English, Czech, Russian, Slovak
See accepted insurances
Accepting New Patients
Offers Telehealth

Veronika Bachanova is a Hematologist Oncology provider practicing medicine in Minneapolis, Minnesota. Dr. Bachanova is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Bachanova is board certified in Hematology: American Board Of Internal Medicine, 2008. Dr. Bachanova is currently accepting new patients.

Expertise in
25
conditions
Dr. Greg M. Vercellotti
Hematology Oncology | Hematology
Expertise in
25
conditions
Dr. Greg M. Vercellotti
Hematology Oncology | Hematology
Referral may be required

M Health Fairview Blood And Marrow Transplant Program Minneapolis

909 Fulton Street Southeast, Suite 214, 
Minneapolis, MN 
 (0.1 miles away)
612-676-4200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Greg Vercellotti is a Hematologist Oncology specialist and a Hematologist practicing medicine in Minneapolis, Minnesota. Dr. Vercellotti is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Vercellotti is board certified in Hematology: American Board Of Internal Medicine, 1982 and Internal Medicine: American Board Of Internal Medicine, 1979. Dr. Vercellotti is currently accepting new patients.

Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

M Health Fairview Masonic Cancer Clinic

909 Fulton Street Southeast, 
Minneapolis, MN 
 (0.1 miles away)
612-676-4200
Languages Spoken:
English, French, Greek
See accepted insurances
Accepting New Patients
Offers Telehealth

Emmanuel Antonarakis is an Oncologist practicing medicine in Minneapolis, Minnesota. Dr. Antonarakis is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, PIK3CA-Related Overgrowth Spectrum, Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Antonarakis is board certified in Medical Oncology: American Board Of Internal Medicine, 2009. Dr. Antonarakis is currently accepting new patients.

Frequently Asked Questions about Dr. Stuart H. Bloom

How do I make an appointment with Dr. Stuart H. Bloom?

You can book an appointment with Dr. Stuart H. Bloom by calling their office at 612-676-4200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Stuart H. Bloom a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Stuart H. Bloom is classified as an Advanced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Stuart H. Bloom specialize in?

While Dr. Stuart H. Bloom is a Hematology Oncology, they have specific expertise in Prostate Cancer, Familial Prostate Cancer, and Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. Stuart H. Bloom participate in research or clinical trials?

Yes. Dr. Stuart H. Bloom has published 3 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Stuart H. Bloom's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Stuart H. Bloom accept my insurance?

Dr. Stuart H. Bloom accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 612-676-4200 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bloom's expertise for a condition
ConditionClose
      View All 11 Advanced Conditions
      View All 82 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile